He also serves as deputy director of Ohio State’s Dorothy M. Davis Heart and Lung Research Institute. Dr. Abraham has been recognized as one of the “Best Doctors in America” for eight consecutive years. Also in 2009 he was named inaugural designated Chair of Excellence in Cardiovascular Medicine at Ohio State’s College of Medicine.
Dr. Abraham earned his medical degree from Harvard Medical School in Boston, Mass., and completed his residency in internal medicine and fellowships in cardiology and heart failure/cardiac transplantation at the University of Colorado Health Sciences Center.
Dr. Abraham is an internationally known researcher in heart failure. Dr. Abraham has received grants from the National Institutes of Health, the American College of Cardiology and the Aetna Quality Care Foundation and has participated as principal investigator in more than 100 multicenter clinical drug and device trials.
In addition to authoring more than 600 original papers, abstracts, book chapters and review articles, Dr. Abraham also co-edited Heart Failure: A Practical Approach to Treatment, a leading textbook on heart failure. Dr. Abraham serves on the editorial boards of several major journals and is a member of many professional organizations. In addition, he is a Fellow of the American College of Cardiology, the American Heart Association and the European Society of Cardiology.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2014
Harvard University School of Medicine
Specialties and conditions I treat
- Cardiovascular Disease
- Heart Failure
- Heart-Assist Devices
- Cardiac Resynchronization Therapy
- Heart Transplantation
- Cardiovascular Diseases
- Coronary Care Units
Locations where I practice
More about my work
University of Colorado School of Medicine
7/1/1990 - 11/30/1993
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Advanced Heart Failure & Transplant Cardiology)
American Board of Internal Medicine (Subspecialty: Cardiovascular)
News about me
- Long-term Effects of Wireless Heart Failure Monitor Just Released
- International Consortium Creates Guidelines for Mitral Valve Repair Trials
- Study Finds Baroreflex Activation Therapy Effectively Treats Heart Failure
- Making Sense of Big Data for Improved Patient Care
- Study: New Device for Heart Failure Safely Improves Heart Function, Quality of Life
- Ohio State First to Implant Newly-Approved Wireless Heart Failure Monitor
- Study Finds Implanted Device Helps Patients With Central Sleep Apnea
- Cardiac Resynchronization Therapy Fails for Certain Heart Failure Patients
- Ohio Cardiologist Honored at Woman's Day Red Dress Award
- Some Heart Tests May Not Be Gauge for Best Treatment
- Bypass Surgery Gets Nod in Large Comparative Study
- Wireless Monitor Reduces Heart Failure Hospitalizations
- New Device May Help Heart Patients With Sleep Apnea
- January 2011 MedTips
- Ohio State Names Women's Cardiovascular Health Leader
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 08/25/2016, Dr. Abraham has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Abbott Vascular
- Amgen, Inc.
- Arca Biopharma, Inc
- Cardiokinetix, Inc.
- Cardiorentis AG
- Cardioxyl Pharmaceuticals, Inc.
- Respicardia, Inc.
- St. Jude Medical, Inc.
- Sunshine Heart, Inc.